Patents by Inventor Anne De Groot

Anne De Groot has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Regulatory T cell epitopes, compositions and uses thereof
    Patent number: 11045528
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: June 29, 2021
    Assignee: EpiVax, Inc.
    Inventors: Anne De Groot, William Martin, Daniel S. Rivera
  • Regulatory T cell epitopes, compositions and uses thereof
    Patent number: 11045529
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: June 29, 2021
    Assignee: EpiVax, Inc.
    Inventors: Anne De Groot, William Martin, Daniel S. Rivera
  • Regulatory T cell epitopes, compositions and uses thereof
    Patent number: 11045530
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: June 29, 2021
    Assignee: EpiVax, Inc.
    Inventors: Anne De Groot, William Martin, Daniel S. Rivera
  • Regulatory T cell epitopes, compositions and uses thereof
    Patent number: 10980867
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Grant
    Filed: March 4, 2019
    Date of Patent: April 20, 2021
    Assignee: EpiVax Inc.
    Inventors: Anne De Groot, William Martin, Daniel S. Rivera
  • Regulatory T cell epitopes, compositions and uses thereof
    Patent number: 10925942
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Grant
    Filed: March 4, 2019
    Date of Patent: February 23, 2021
    Assignee: EpiVax, Inc.
    Inventors: Anne De Groot, William Martin, Daniel S. Rivera
  • Regulatory T cell epitopes, compositions and uses thereof
    Patent number: 10925940
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: February 23, 2021
    Assignee: EpiVax, Inc.
    Inventors: Anne De Groot, William Martin, Daniel S. Rivera
  • Regulatory T cell epitopes, compositions and uses thereof
    Patent number: 10925939
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: February 23, 2021
    Assignee: EpiVax, Inc.
    Inventors: Anne De Groot, William Martin, Daniel S. Rivera
  • Regulatory T cell epitopes, compositions and uses thereof
    Patent number: 10925941
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Grant
    Filed: October 16, 2018
    Date of Patent: February 23, 2021
    Assignee: EpiVax, Inc.
    Inventors: Anne De Groot, William Martin, Daniel S. Rivera
  • Regulatory T cell epitopes, compositions and uses thereof
    Patent number: 10751397
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: August 25, 2020
    Assignee: EpiVax, Inc.
    Inventors: Anne De Groot, William Martin, Daniel S. Rivera
  • REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF
    Publication number: 20190351036
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Application
    Filed: August 2, 2019
    Publication date: November 21, 2019
    Applicant: EpiVax, Inc.
    Inventors: Anne De Groot, William Martin, Daniel S. Rivera
  • REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF
    Publication number: 20190183994
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Application
    Filed: March 4, 2019
    Publication date: June 20, 2019
    Applicant: EpiVax, Inc.
    Inventors: Anne De Groot, William Martin, Daniel S. Rivera
  • REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF
    Publication number: 20190183993
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Application
    Filed: March 4, 2019
    Publication date: June 20, 2019
    Applicant: EpiVax, Inc.
    Inventors: Anne De Groot, William Martin, Daniel S. Rivera
  • Regulatory T cell epitopes, compositions and uses thereof
    Patent number: 10213496
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Grant
    Filed: September 17, 2015
    Date of Patent: February 26, 2019
    Assignee: EPIVAX, INC.
    Inventors: Anne De Groot, William Martin, Daniel S. Rivera
  • REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF
    Publication number: 20190030143
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Application
    Filed: October 16, 2018
    Publication date: January 31, 2019
    Applicant: EpiVax, Inc.
    Inventors: Anne De Groot, William Martin, Daniel S. Rivera
  • REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF
    Publication number: 20190030144
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Application
    Filed: October 16, 2018
    Publication date: January 31, 2019
    Applicant: EpiVax, Inc.
    Inventors: Anne De Groot, William Martin, Daniel S. Rivera
  • REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF
    Publication number: 20180289787
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Application
    Filed: June 22, 2018
    Publication date: October 11, 2018
    Applicant: EpiVax, Inc.
    Inventors: Anne DE GROOT, William MARTIN, Daniel S. RIVERA
  • REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF
    Publication number: 20180289783
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Application
    Filed: June 22, 2018
    Publication date: October 11, 2018
    Applicant: EpiVax, Inc.
    Inventors: Anne DE GROOT, William MARTIN, Daniel S. RIVERA
  • REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF
    Publication number: 20180289786
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Application
    Filed: June 22, 2018
    Publication date: October 11, 2018
    Applicant: EpiVax, Inc.
    Inventors: Anne DE GROOT, William MARTIN, Daniel S. RIVERA
  • REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF
    Publication number: 20180289788
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Application
    Filed: June 22, 2018
    Publication date: October 11, 2018
    Applicant: EpiVax, Inc.
    Inventors: Anne DE GROOT, William MARTIN, Daniel S. RIVERA
  • REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF
    Publication number: 20180289785
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Application
    Filed: June 22, 2018
    Publication date: October 11, 2018
    Applicant: EpiVax, Inc.
    Inventors: Anne DE GROOT, William MARTIN, Daniel S. RIVERA